NuFund Venture Group — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

VerImmuneverimmune.com in 𝕏Jul 2022 · $2.5M

VerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity.

BiotechHealthtechMedical DevicesBethesda, US

JOSHUA WANG(Executive Officer, Director, Promoter)inJOHN TROYER(Executive Officer)

BoardCYNTHIA POH(Director)KEVIN KOH RONGSHENG(Director)HAOLIN SUNG(Director)inCHE HSU(Director)in

Co-investorsMaryland TEDCO Ulu Ventures Gaingels Mana Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.